First unit in China to produce both propylene and isobutylene in a single unit; only the second unit of its kind in the world
DES PLAINES, Ill., April 25, 2012 — UOP LLC, a Honeywell (NYSE: HON) company, announced today that its UOP C3 and C4 Oleflex™ processes have been selected by China’s Shandong Chambroad Petrochemicals Co. to produce key petrochemicals.
The plant will be the first in China, and only the second in the world, to combine both processes, which are used to produce propylene and isobutylene, respectively. Propylene is a building block material used in the production of films and packaging, while isobutylene is a key ingredient for fuels and synthetic rubber.
“As the demand for petrochemicals grows, especially in China, producers are looking for opportunities to integrate processes to maximize product yields and reduce production costs,” said Pete Piotrowski, senior vice president and general manager for Process Technology and Equipment at Honeywell’s UOP. “China’s propylene consumption accounts for more than 15 percent of worldwide demand and is expected to grow by 5 to 6 percent per year. This is the first plant in the region to integrate our C3 and C4 Oleflex technology in a single unit and this project will help meet demand more efficiently, while improving the facility’s return on investment. This is a milestone for the region’s petrochemical production and we look forward to working with Chambroad on this project.”
The new units, expected to start up in 2014, will produce 133,000 metric tons of propylene and 87,000 metric tons of isobutylene annually at its facility in Binzhou City, Shandong Province, China. Honeywell’s UOP will provide the engineering design, technology licensing, catalysts, adsorbents, equipment, staff training and technical service for the project.
The C3 Oleflex process uses catalytic dehydrogenation to convert propane to propylene. The C4 Oleflex process uses catalytic dehydrogenation to convert isobutane to isobutylene. Using mixed dehydrogenation, the processes will be combined to produce both materials in a single unit.
Compared with competing processes, Oleflex technology provides the lowest cash cost of production and the highest return on investment, enabled by low operating and capital costs, high propylene yield and reliability, and maximum operating flexibility.
Since the technology was commercialized in 1990, Honeywell’s UOP has commissioned nine C3 Oleflex units for on-purpose propylene production, with the 10th unit scheduled to start-up this year in Russia. This is the eighth C3 Oleflex project Honeywell’s UOP has announced since the beginning of 2011. Those projects, located in China, Abu Dhabi and North America, are expected to produce nearly 5 million metric tons of propylene in the next three years. There are currently five C4 Oleflex units in operation, producing nearly 2 million metric tons of isobutylene annually.
Shandong Chambroad Petrochemicals Co. Ltd. is a fully owned subsidiary of Shandong Chambroad Holding Co. Ltd and is headquartered in Binzhou City, Shandong Province, China.
UOP LLC, headquartered in Des Plaines, Illinois, USA, is a leading international supplier and licensor of process technology, catalysts, adsorbents, process plants, and consulting services to the petroleum refining, petrochemical, and gas processing industries. UOP is a wholly-owned subsidiary of Honeywell International, Inc. and is part of Honeywell’s Performance Materials and Technologies strategic business group. For more information, go to www.uop.com.
Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes and industry; turbochargers; and specialty materials. Based in Morris Township, N.J., Honeywell’s shares are traded on the New York, London, and Chicago Stock Exchanges. For more news and information on Honeywell, please visit www.honeywellnow.com.
This release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Forward-looking statements are based on management’s assumptions and assessments in light of past experience and trends, current conditions, expected future developments and other relevant factors. They are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by our forward-looking statements. Our forward-looking statements are also subject to risks and uncertainties, which can affect our performance in both the near- and long-term. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.
# # #